Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The company is already marketing the 4 mg and 10 mg strengths
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Subscribe To Our Newsletter & Stay Updated
